Global Cough and Cold Preparations Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 112
Inquire Before Buying

Cough and Cold Preparations market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cough and Cold Preparations market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- by Dosage Type

- - Tablet

- - Solution

- - Drops

- - Capsule

- - Granules

- - Syrup

- - Pills

- by Drug Type

- - Antihistamines

- - Expectorants

- - Bronchodilators

- - Decongestants

- - Antibiotics

- - Others

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Drug Stores

- Supermarkets/Hypermarkets

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- GlaxoSmithKline

- AstraZeneca

- Bayer

- Blackmores Limited

- Dabur

- Johnson & Johnson

- Reckitt Benckiser

- Pfizer

- Sun Pharmaceutical

- Novartis

- Prestige Brands

- Procter & Gamble

- Toray Industries

- Beijing Tongrentang

- Essence Pharmaceutical Group

- Jiangxi Heying Pharmaceutical

- Diao Group Chengdu Pharmaceutical

- Shanghai Pharmaceutical

- Harbin Children's Pharmaceutical

- China Resources Sanjiu Pharmaceutical

- Xinjiang Quanan Pharmaceutical

- Jiangsu Huayang Pharmaceutical

- Nanjing Chengong Pharmaceutical

- Beijing Jiulong Pharmaceutical

- Livzon Group

- Sinopharm Group

- CSPC

- Perrigo Company

- Vernalis

- Tris Pharma

- Acella Pharmaceuticals

Global Cough and Cold Preparations Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Dosage Type
1.2.1 Global Cough and Cold Preparations Market Size Growth Rate by Dosage Type: 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Solution
1.2.4 Drops
1.2.5 Capsule
1.2.6 Granules
1.2.7 Syrup
1.2.8 Pills
1.3 Market by Application
1.3.1 Global Cough and Cold Preparations Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Drug Stores
1.3.5 Supermarkets/Hypermarkets
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cough and Cold Preparations Market Perspective (2017-2028)
2.2 Cough and Cold Preparations Growth Trends by Region
2.2.1 Cough and Cold Preparations Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cough and Cold Preparations Historic Market Size by Region (2017-2022)
2.2.3 Cough and Cold Preparations Forecasted Market Size by Region (2023-2028)
2.3 Cough and Cold Preparations Market Dynamics
2.3.1 Cough and Cold Preparations Industry Trends
2.3.2 Cough and Cold Preparations Market Drivers
2.3.3 Cough and Cold Preparations Market Challenges
2.3.4 Cough and Cold Preparations Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cough and Cold Preparations Players by Revenue
3.1.1 Global Top Cough and Cold Preparations Players by Revenue (2017-2022)
3.1.2 Global Cough and Cold Preparations Revenue Market Share by Players (2017-2022)
3.2 Global Cough and Cold Preparations Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cough and Cold Preparations Revenue
3.4 Global Cough and Cold Preparations Market Concentration Ratio
3.4.1 Global Cough and Cold Preparations Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cough and Cold Preparations Revenue in 2021
3.5 Cough and Cold Preparations Key Players Head office and Area Served
3.6 Key Players Cough and Cold Preparations Product Solution and Service
3.7 Date of Enter into Cough and Cold Preparations Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cough and Cold Preparations Breakdown Data by Type
4.1 Global Cough and Cold Preparations Historic Market Size by Type (2017-2022)
4.2 Global Cough and Cold Preparations Forecasted Market Size by Type (2023-2028)
5 Cough and Cold Preparations Breakdown Data by Application
5.1 Global Cough and Cold Preparations Historic Market Size by Application (2017-2022)
5.2 Global Cough and Cold Preparations Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cough and Cold Preparations Market Size (2017-2028)
6.2 North America Cough and Cold Preparations Market Size by Country (2017-2022)
6.3 North America Cough and Cold Preparations Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cough and Cold Preparations Market Size (2017-2028)
7.2 Europe Cough and Cold Preparations Market Size by Country (2017-2022)
7.3 Europe Cough and Cold Preparations Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cough and Cold Preparations Market Size (2017-2028)
8.2 Asia-Pacific Cough and Cold Preparations Market Size by Country (2017-2022)
8.3 Asia-Pacific Cough and Cold Preparations Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cough and Cold Preparations Market Size (2017-2028)
9.2 Latin America Cough and Cold Preparations Market Size by Country (2017-2022)
9.3 Latin America Cough and Cold Preparations Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cough and Cold Preparations Market Size (2017-2028)
10.2 Middle East & Africa Cough and Cold Preparations Market Size by Country (2017-2022)
10.3 Middle East & Africa Cough and Cold Preparations Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Cough and Cold Preparations Introduction
11.1.4 GlaxoSmithKline Revenue in Cough and Cold Preparations Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cough and Cold Preparations Introduction
11.2.4 AstraZeneca Revenue in Cough and Cold Preparations Business (2017-2022)
11.2.5 AstraZeneca Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Cough and Cold Preparations Introduction
11.3.4 Bayer Revenue in Cough and Cold Preparations Business (2017-2022)
11.3.5 Bayer Recent Development
11.4 Blackmores Limited
11.4.1 Blackmores Limited Company Detail
11.4.2 Blackmores Limited Business Overview
11.4.3 Blackmores Limited Cough and Cold Preparations Introduction
11.4.4 Blackmores Limited Revenue in Cough and Cold Preparations Business (2017-2022)
11.4.5 Blackmores Limited Recent Development
11.5 Dabur
11.5.1 Dabur Company Detail
11.5.2 Dabur Business Overview
11.5.3 Dabur Cough and Cold Preparations Introduction
11.5.4 Dabur Revenue in Cough and Cold Preparations Business (2017-2022)
11.5.5 Dabur Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Cough and Cold Preparations Introduction
11.6.4 Johnson & Johnson Revenue in Cough and Cold Preparations Business (2017-2022)
11.6.5 Johnson & Johnson Recent Development
11.7 Reckitt Benckiser
11.7.1 Reckitt Benckiser Company Detail
11.7.2 Reckitt Benckiser Business Overview
11.7.3 Reckitt Benckiser Cough and Cold Preparations Introduction
11.7.4 Reckitt Benckiser Revenue in Cough and Cold Preparations Business (2017-2022)
11.7.5 Reckitt Benckiser Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Cough and Cold Preparations Introduction
11.8.4 Pfizer Revenue in Cough and Cold Preparations Business (2017-2022)
11.8.5 Pfizer Recent Development
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Detail
11.9.2 Sun Pharmaceutical Business Overview
11.9.3 Sun Pharmaceutical Cough and Cold Preparations Introduction
11.9.4 Sun Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.9.5 Sun Pharmaceutical Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Cough and Cold Preparations Introduction
11.10.4 Novartis Revenue in Cough and Cold Preparations Business (2017-2022)
11.10.5 Novartis Recent Development
11.11 Prestige Brands
11.11.1 Prestige Brands Company Detail
11.11.2 Prestige Brands Business Overview
11.11.3 Prestige Brands Cough and Cold Preparations Introduction
11.11.4 Prestige Brands Revenue in Cough and Cold Preparations Business (2017-2022)
11.11.5 Prestige Brands Recent Development
11.12 Procter & Gamble
11.12.1 Procter & Gamble Company Detail
11.12.2 Procter & Gamble Business Overview
11.12.3 Procter & Gamble Cough and Cold Preparations Introduction
11.12.4 Procter & Gamble Revenue in Cough and Cold Preparations Business (2017-2022)
11.12.5 Procter & Gamble Recent Development
11.13 Toray Industries
11.13.1 Toray Industries Company Detail
11.13.2 Toray Industries Business Overview
11.13.3 Toray Industries Cough and Cold Preparations Introduction
11.13.4 Toray Industries Revenue in Cough and Cold Preparations Business (2017-2022)
11.13.5 Toray Industries Recent Development
11.14 Beijing Tongrentang
11.14.1 Beijing Tongrentang Company Detail
11.14.2 Beijing Tongrentang Business Overview
11.14.3 Beijing Tongrentang Cough and Cold Preparations Introduction
11.14.4 Beijing Tongrentang Revenue in Cough and Cold Preparations Business (2017-2022)
11.14.5 Beijing Tongrentang Recent Development
11.15 Essence Pharmaceutical Group
11.15.1 Essence Pharmaceutical Group Company Detail
11.15.2 Essence Pharmaceutical Group Business Overview
11.15.3 Essence Pharmaceutical Group Cough and Cold Preparations Introduction
11.15.4 Essence Pharmaceutical Group Revenue in Cough and Cold Preparations Business (2017-2022)
11.15.5 Essence Pharmaceutical Group Recent Development
11.16 Jiangxi Heying Pharmaceutical
11.16.1 Jiangxi Heying Pharmaceutical Company Detail
11.16.2 Jiangxi Heying Pharmaceutical Business Overview
11.16.3 Jiangxi Heying Pharmaceutical Cough and Cold Preparations Introduction
11.16.4 Jiangxi Heying Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.16.5 Jiangxi Heying Pharmaceutical Recent Development
11.17 Diao Group Chengdu Pharmaceutical
11.17.1 Diao Group Chengdu Pharmaceutical Company Detail
11.17.2 Diao Group Chengdu Pharmaceutical Business Overview
11.17.3 Diao Group Chengdu Pharmaceutical Cough and Cold Preparations Introduction
11.17.4 Diao Group Chengdu Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.17.5 Diao Group Chengdu Pharmaceutical Recent Development
11.18 Shanghai Pharmaceutical
11.18.1 Shanghai Pharmaceutical Company Detail
11.18.2 Shanghai Pharmaceutical Business Overview
11.18.3 Shanghai Pharmaceutical Cough and Cold Preparations Introduction
11.18.4 Shanghai Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.18.5 Shanghai Pharmaceutical Recent Development
11.19 Harbin Children's Pharmaceutical
11.19.1 Harbin Children's Pharmaceutical Company Detail
11.19.2 Harbin Children's Pharmaceutical Business Overview
11.19.3 Harbin Children's Pharmaceutical Cough and Cold Preparations Introduction
11.19.4 Harbin Children's Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.19.5 Harbin Children's Pharmaceutical Recent Development
11.20 China Resources Sanjiu Pharmaceutical
11.20.1 China Resources Sanjiu Pharmaceutical Company Detail
11.20.2 China Resources Sanjiu Pharmaceutical Business Overview
11.20.3 China Resources Sanjiu Pharmaceutical Cough and Cold Preparations Introduction
11.20.4 China Resources Sanjiu Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.20.5 China Resources Sanjiu Pharmaceutical Recent Development
11.21 Xinjiang Quanan Pharmaceutical
11.21.1 Xinjiang Quanan Pharmaceutical Company Detail
11.21.2 Xinjiang Quanan Pharmaceutical Business Overview
11.21.3 Xinjiang Quanan Pharmaceutical Cough and Cold Preparations Introduction
11.21.4 Xinjiang Quanan Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.21.5 Xinjiang Quanan Pharmaceutical Recent Development
11.22 Jiangsu Huayang Pharmaceutical
11.22.1 Jiangsu Huayang Pharmaceutical Company Detail
11.22.2 Jiangsu Huayang Pharmaceutical Business Overview
11.22.3 Jiangsu Huayang Pharmaceutical Cough and Cold Preparations Introduction
11.22.4 Jiangsu Huayang Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.22.5 Jiangsu Huayang Pharmaceutical Recent Development
11.23 Nanjing Chengong Pharmaceutical
11.23.1 Nanjing Chengong Pharmaceutical Company Detail
11.23.2 Nanjing Chengong Pharmaceutical Business Overview
11.23.3 Nanjing Chengong Pharmaceutical Cough and Cold Preparations Introduction
11.23.4 Nanjing Chengong Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.23.5 Nanjing Chengong Pharmaceutical Recent Development
11.24 Beijing Jiulong Pharmaceutical
11.24.1 Beijing Jiulong Pharmaceutical Company Detail
11.24.2 Beijing Jiulong Pharmaceutical Business Overview
11.24.3 Beijing Jiulong Pharmaceutical Cough and Cold Preparations Introduction
11.24.4 Beijing Jiulong Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022)
11.24.5 Beijing Jiulong Pharmaceutical Recent Development
11.25 Livzon Group
11.25.1 Livzon Group Company Detail
11.25.2 Livzon Group Business Overview
11.25.3 Livzon Group Cough and Cold Preparations Introduction
11.25.4 Livzon Group Revenue in Cough and Cold Preparations Business (2017-2022)
11.25.5 Livzon Group Recent Development
11.26 Sinopharm Group
11.26.1 Sinopharm Group Company Detail
11.26.2 Sinopharm Group Business Overview
11.26.3 Sinopharm Group Cough and Cold Preparations Introduction
11.26.4 Sinopharm Group Revenue in Cough and Cold Preparations Business (2017-2022)
11.26.5 Sinopharm Group Recent Development
11.27 CSPC
11.27.1 CSPC Company Detail
11.27.2 CSPC Business Overview
11.27.3 CSPC Cough and Cold Preparations Introduction
11.27.4 CSPC Revenue in Cough and Cold Preparations Business (2017-2022)
11.27.5 CSPC Recent Development
11.28 Perrigo Company
11.28.1 Perrigo Company Company Detail
11.28.2 Perrigo Company Business Overview
11.28.3 Perrigo Company Cough and Cold Preparations Introduction
11.28.4 Perrigo Company Revenue in Cough and Cold Preparations Business (2017-2022)
11.28.5 Perrigo Company Recent Development
11.29 Vernalis
11.29.1 Vernalis Company Detail
11.29.2 Vernalis Business Overview
11.29.3 Vernalis Cough and Cold Preparations Introduction
11.29.4 Vernalis Revenue in Cough and Cold Preparations Business (2017-2022)
11.29.5 Vernalis Recent Development
11.30 Tris Pharma
11.30.1 Tris Pharma Company Detail
11.30.2 Tris Pharma Business Overview
11.30.3 Tris Pharma Cough and Cold Preparations Introduction
11.30.4 Tris Pharma Revenue in Cough and Cold Preparations Business (2017-2022)
11.30.5 Tris Pharma Recent Development
11.31 Acella Pharmaceuticals
11.31.1 Acella Pharmaceuticals Company Detail
11.31.2 Acella Pharmaceuticals Business Overview
11.31.3 Acella Pharmaceuticals Cough and Cold Preparations Introduction
11.31.4 Acella Pharmaceuticals Revenue in Cough and Cold Preparations Business (2017-2022)
11.31.5 Acella Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cough and Cold Preparations Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Tablet
Table 3. Key Players of Solution
Table 4. Key Players of Drops
Table 5. Key Players of Capsule
Table 6. Key Players of Granules
Table 7. Key Players of Syrup
Table 8. Key Players of Pills
Table 9. Global Cough and Cold Preparations Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Cough and Cold Preparations Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Cough and Cold Preparations Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Cough and Cold Preparations Market Share by Region (2017-2022)
Table 13. Global Cough and Cold Preparations Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Cough and Cold Preparations Market Share by Region (2023-2028)
Table 15. Cough and Cold Preparations Market Trends
Table 16. Cough and Cold Preparations Market Drivers
Table 17. Cough and Cold Preparations Market Challenges
Table 18. Cough and Cold Preparations Market Restraints
Table 19. Global Cough and Cold Preparations Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Cough and Cold Preparations Market Share by Players (2017-2022)
Table 21. Global Top Cough and Cold Preparations Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cough and Cold Preparations as of 2021)
Table 22. Ranking of Global Top Cough and Cold Preparations Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Cough and Cold Preparations Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cough and Cold Preparations Product Solution and Service
Table 26. Date of Enter into Cough and Cold Preparations Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cough and Cold Preparations Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Cough and Cold Preparations Revenue Market Share by Type (2017-2022)
Table 30. Global Cough and Cold Preparations Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Cough and Cold Preparations Revenue Market Share by Type (2023-2028)
Table 32. Global Cough and Cold Preparations Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Cough and Cold Preparations Revenue Market Share by Application (2017-2022)
Table 34. Global Cough and Cold Preparations Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Cough and Cold Preparations Revenue Market Share by Application (2023-2028)
Table 36. North America Cough and Cold Preparations Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Cough and Cold Preparations Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Cough and Cold Preparations Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Cough and Cold Preparations Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Cough and Cold Preparations Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Cough and Cold Preparations Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Cough and Cold Preparations Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Cough and Cold Preparations Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Cough and Cold Preparations Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Cough and Cold Preparations Market Size by Country (2023-2028) & (US$ Million)
Table 46. GlaxoSmithKline Company Detail
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Cough and Cold Preparations Product
Table 49. GlaxoSmithKline Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Cough and Cold Preparations Product
Table 54. AstraZeneca Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Bayer Company Detail
Table 57. Bayer Business Overview
Table 58. Bayer Cough and Cold Preparations Product
Table 59. Bayer Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 60. Bayer Recent Development
Table 61. Blackmores Limited Company Detail
Table 62. Blackmores Limited Business Overview
Table 63. Blackmores Limited Cough and Cold Preparations Product
Table 64. Blackmores Limited Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 65. Blackmores Limited Recent Development
Table 66. Dabur Company Detail
Table 67. Dabur Business Overview
Table 68. Dabur Cough and Cold Preparations Product
Table 69. Dabur Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 70. Dabur Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Cough and Cold Preparations Product
Table 74. Johnson & Johnson Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Reckitt Benckiser Company Detail
Table 77. Reckitt Benckiser Business Overview
Table 78. Reckitt Benckiser Cough and Cold Preparations Product
Table 79. Reckitt Benckiser Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 80. Reckitt Benckiser Recent Development
Table 81. Pfizer Company Detail
Table 82. Pfizer Business Overview
Table 83. Pfizer Cough and Cold Preparations Product
Table 84. Pfizer Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Sun Pharmaceutical Company Detail
Table 87. Sun Pharmaceutical Business Overview
Table 88. Sun Pharmaceutical Cough and Cold Preparations Product
Table 89. Sun Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 90. Sun Pharmaceutical Recent Development
Table 91. Novartis Company Detail
Table 92. Novartis Business Overview
Table 93. Novartis Cough and Cold Preparations Product
Table 94. Novartis Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Prestige Brands Company Detail
Table 97. Prestige Brands Business Overview
Table 98. Prestige Brands Cough and Cold PreparationsProduct
Table 99. Prestige Brands Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 100. Prestige Brands Recent Development
Table 101. Procter & Gamble Company Detail
Table 102. Procter & Gamble Business Overview
Table 103. Procter & Gamble Cough and Cold PreparationsProduct
Table 104. Procter & Gamble Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 105. Procter & Gamble Recent Development
Table 106. Toray Industries Company Detail
Table 107. Toray Industries Business Overview
Table 108. Toray Industries Cough and Cold PreparationsProduct
Table 109. Toray Industries Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 110. Toray Industries Recent Development
Table 111. Beijing Tongrentang Company Detail
Table 112. Beijing Tongrentang Business Overview
Table 113. Beijing Tongrentang Cough and Cold PreparationsProduct
Table 114. Beijing Tongrentang Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 115. Beijing Tongrentang Recent Development
Table 116. Essence Pharmaceutical Group Company Detail
Table 117. Essence Pharmaceutical Group Business Overview
Table 118. Essence Pharmaceutical Group Cough and Cold PreparationsProduct
Table 119. Essence Pharmaceutical Group Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 120. Essence Pharmaceutical Group Recent Development
Table 121. Jiangxi Heying Pharmaceutical Company Detail
Table 122. Jiangxi Heying Pharmaceutical Business Overview
Table 123. Jiangxi Heying Pharmaceutical Cough and Cold PreparationsProduct
Table 124. Jiangxi Heying Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 125. Jiangxi Heying Pharmaceutical Recent Development
Table 126. Diao Group Chengdu Pharmaceutical Company Detail
Table 127. Diao Group Chengdu Pharmaceutical Business Overview
Table 128. Diao Group Chengdu Pharmaceutical Cough and Cold PreparationsProduct
Table 129. Diao Group Chengdu Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 130. Diao Group Chengdu Pharmaceutical Recent Development
Table 131. Shanghai Pharmaceutical Company Detail
Table 132. Shanghai Pharmaceutical Business Overview
Table 133. Shanghai Pharmaceutical Cough and Cold PreparationsProduct
Table 134. Shanghai Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 135. Shanghai Pharmaceutical Recent Development
Table 136. Harbin Children's Pharmaceutical Company Detail
Table 137. Harbin Children's Pharmaceutical Business Overview
Table 138. Harbin Children's Pharmaceutical Cough and Cold PreparationsProduct
Table 139. Harbin Children's Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 140. Harbin Children's Pharmaceutical Recent Development
Table 141. China Resources Sanjiu Pharmaceutical Company Detail
Table 142. China Resources Sanjiu Pharmaceutical Business Overview
Table 143. China Resources Sanjiu Pharmaceutical Cough and Cold PreparationsProduct
Table 144. China Resources Sanjiu Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 145. China Resources Sanjiu Pharmaceutical Recent Development
Table 146. Xinjiang Quanan Pharmaceutical Company Detail
Table 147. Xinjiang Quanan Pharmaceutical Business Overview
Table 148. Xinjiang Quanan Pharmaceutical Cough and Cold PreparationsProduct
Table 149. Xinjiang Quanan Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 150. Xinjiang Quanan Pharmaceutical Recent Development
Table 151. Jiangsu Huayang Pharmaceutical Company Detail
Table 152. Jiangsu Huayang Pharmaceutical Business Overview
Table 153. Jiangsu Huayang Pharmaceutical Cough and Cold PreparationsProduct
Table 154. Jiangsu Huayang Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 155. Jiangsu Huayang Pharmaceutical Recent Development
Table 156. Nanjing Chengong Pharmaceutical Company Detail
Table 157. Nanjing Chengong Pharmaceutical Business Overview
Table 158. Nanjing Chengong Pharmaceutical Cough and Cold PreparationsProduct
Table 159. Nanjing Chengong Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 160. Nanjing Chengong Pharmaceutical Recent Development
Table 161. Beijing Jiulong Pharmaceutical Company Detail
Table 162. Beijing Jiulong Pharmaceutical Business Overview
Table 163. Beijing Jiulong Pharmaceutical Cough and Cold PreparationsProduct
Table 164. Beijing Jiulong Pharmaceutical Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 165. Beijing Jiulong Pharmaceutical Recent Development
Table 166. Livzon Group Company Detail
Table 167. Livzon Group Business Overview
Table 168. Livzon Group Cough and Cold PreparationsProduct
Table 169. Livzon Group Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 170. Livzon Group Recent Development
Table 171. Sinopharm Group Company Detail
Table 172. Sinopharm Group Business Overview
Table 173. Sinopharm Group Cough and Cold PreparationsProduct
Table 174. Sinopharm Group Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 175. Sinopharm Group Recent Development
Table 176. CSPC Company Detail
Table 177. CSPC Business Overview
Table 178. CSPC Cough and Cold PreparationsProduct
Table 179. CSPC Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 180. CSPC Recent Development
Table 181. Perrigo Company Company Detail
Table 182. Perrigo Company Business Overview
Table 183. Perrigo Company Cough and Cold PreparationsProduct
Table 184. Perrigo Company Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 185. Perrigo Company Recent Development
Table 186. Vernalis Company Detail
Table 187. Vernalis Business Overview
Table 188. Vernalis Cough and Cold PreparationsProduct
Table 189. Vernalis Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 190. Vernalis Recent Development
Table 191. Tris Pharma Company Detail
Table 192. Tris Pharma Business Overview
Table 193. Tris Pharma Cough and Cold PreparationsProduct
Table 194. Tris Pharma Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 195. Tris Pharma Recent Development
Table 196. Acella Pharmaceuticals Company Detail
Table 197. Acella Pharmaceuticals Business Overview
Table 198. Acella Pharmaceuticals Cough and Cold Preparations Product
Table 199. Acella Pharmaceuticals Revenue in Cough and Cold Preparations Business (2017-2022) & (US$ Million)
Table 200. Acella Pharmaceuticals Recent Development
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cough and Cold Preparations Market Share by Type: 2021 VS 2028
Figure 2. Tablet Features
Figure 3. Solution Features
Figure 4. Drops Features
Figure 5. Capsule Features
Figure 6. Granules Features
Figure 7. Syrup Features
Figure 8. Pills Features
Figure 9. Global Cough and Cold Preparations Market Share by Application in 2021 & 2028
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Drug Stores Case Studies
Figure 13. Supermarkets/Hypermarkets Case Studies
Figure 14. Others Case Studies
Figure 15. Cough and Cold Preparations Report Years Considered
Figure 16. Global Cough and Cold Preparations Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Cough and Cold Preparations Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Cough and Cold Preparations Market Share by Region: 2021 VS 2028
Figure 19. Global Cough and Cold Preparations Market Share by Players in 2021
Figure 20. Global Top Cough and Cold Preparations Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cough and Cold Preparations as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Cough and Cold Preparations Revenue in 2021
Figure 22. North America Cough and Cold Preparations Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America Cough and Cold Preparations Market Share by Country (2017-2028)
Figure 24. United States Cough and Cold Preparations Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Cough and Cold Preparations Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Cough and Cold Preparations Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Cough and Cold Preparations Market Share by Country (2017-2028)
Figure 28. Germany Cough and Cold Preparations Mark
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs